What does SPIL mean in COMPANIES & FIRMS
SPIL stands for SciClone Pharmaceuticals International Ltd. It is a global biopharmaceutical company that focuses on developing and commercializing innovative therapies for cancer and other life-threatening diseases.
SPIL meaning in Companies & Firms in Business
SPIL mostly used in an acronym Companies & Firms in Category Business that means SciClone Pharmaceuticals International Ltd
Shorthand: SPIL,
Full Form: SciClone Pharmaceuticals International Ltd
For more information of "SciClone Pharmaceuticals International Ltd", see the section below.
SPIL: Overview
- SPIL is headquartered in Foster City, California, USA.
- The company was founded in 2003 and has operations in over 70 countries.
- SPIL's primary focus is on developing and commercializing targeted therapies for cancer, specifically in the areas of hematology and oncology.
- The company has a strong pipeline of investigational drugs in various stages of development, including both small molecules and biologics.
SPIL: Key Products
- Zejula (niraparib): A PARP inhibitor approved for the treatment of advanced ovarian cancer and certain other cancers.
- Adcetris (brentuximab vedotin): An antibody-drug conjugate approved for the treatment of various types of lymphoma.
- Myrbetriq (mirabegron): An overactive bladder treatment.
SPIL: Financial Performance
- SPIL reported total revenues of approximately $1.5 billion in 2021.
- The company has a strong financial position with over $1 billion in cash and investments.
Essential Questions and Answers on SciClone Pharmaceuticals International Ltd in "BUSINESS»FIRMS"
What is SciClone Pharmaceuticals International Ltd. (SPIL)?
SciClone Pharmaceuticals International Ltd. (SPIL) is a biopharmaceutical company that specializes in developing and marketing innovative cancer treatments. The company operates in multiple countries and has a portfolio of products that includes both branded and generic drugs.
What are SPIL's primary areas of focus?
SPIL's primary areas of focus are oncology and hematology. The company develops and markets treatments for a variety of cancers, including lung cancer, breast cancer, and lymphoma.
What are SPIL's key products?
SPIL's key products include Zolinza (vorinostat), which is used to treat cutaneous T-cell lymphoma, and Adcetris (brentuximab vedotin), which is used to treat Hodgkin lymphoma and anaplastic large cell lymphoma.
Where does SPIL operate?
SPIL operates in multiple countries around the world, including the United States, China, and Europe. The company has a global reach and is committed to providing access to its products to patients in need.
What is SPIL's financial performance?
SPIL's financial performance has been strong in recent years. The company has reported steady revenue and profit growth, and its products have been well-received by the market. SPIL is well-positioned for continued growth in the future.
Final Words: SPIL is a leading biopharmaceutical company with a strong focus on developing and commercializing innovative therapies for cancer and other life-threatening diseases. The company's commitment to research and development, along with its strong financial position, positions it well for continued growth and success in the future.
SPIL also stands for: |
|
| All stands for SPIL |